[Left ventricular thrombosis after acute myocardial infarction: relationship with thrombolytic therapy and the patency of the "guilty" vessel].
Pizzetti
G
G
Divisione di Cardiologia, Istituto Scientifico H San Raffaele, Milano.
Belotti
G
G
Chierchia
S L
SL
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006352:Heart Ventricles; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D014654:Vascular Patency
D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator; D001241:Aspirin
Trombosi ventricolare sinistra dopo infarto miocardico acuto: relazione con la terapia trombolitica e la pervietà del vaso "colpevole".